Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 393

1.

Fifty years of digestive endoscopy: Successes, setbacks, solutions and the future.

Axon ATR.

Dig Endosc. 2019 Dec 3. doi: 10.1111/den.13593. [Epub ahead of print]

PMID:
31794063
2.

Epidemiology of Helicobacter pylori infection.

Burucoa C, Axon A.

Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12403. Review.

PMID:
28891138
3.

Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse.

Meyer SK, Probert PME, Lakey AF, Axon AR, Leitch AC, Williams FM, Jowsey PA, Blain PG, Kass GEN, Wright MC.

Toxicol Lett. 2017 May 5;273:55-68. doi: 10.1016/j.toxlet.2017.03.024. Epub 2017 Mar 27.

4.

Quality assurance in gastrointestinal endoscopy: An Egyptian experience.

Gado AS, Ebeid BA, Axon AT.

Arab J Gastroenterol. 2016 Dec;17(4):153-158. doi: 10.1016/j.ajg.2016.11.002. Epub 2016 Dec 15. Review.

PMID:
27988235
5.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel.

Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

PMID:
27707777
6.

Epidemiology of Helicobacter pylori infection.

Leja M, Axon A, Brenner H.

Helicobacter. 2016 Sep;21 Suppl 1:3-7. doi: 10.1111/hel.12332. Review.

PMID:
27531531
7.

Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan.

Kono S, Gotoda T, Yoshida S, Oda I, Kondo H, Gatta L, Naylor G, Dixon M, Moriyasu F, Axon A.

World J Gastroenterol. 2015 Dec 14;21(46):13113-23. doi: 10.3748/wjg.v21.i46.13113.

8.

Helicobacter pylori and Nonmalignant Diseases.

Potamitis GS, Axon AT.

Helicobacter. 2015 Sep;20 Suppl 1:26-9. doi: 10.1111/hel.12253. Review.

PMID:
26372821
9.

Helicobacter pylori and public health.

Axon A.

Helicobacter. 2014 Sep;19 Suppl 1:68-73. doi: 10.1111/hel.12155. Review.

PMID:
25167948
10.

Guidelines for designing a digestive disease endoscopy unit: report of the World Endoscopy Organization.

Mulder CJ, Jacobs MA, Leicester RJ, Nageshwar Reddy D, Shepherd LE, Axon AT, Waye JD.

Dig Endosc. 2013 Jul;25(4):365-75. doi: 10.1111/den.12126. Epub 2013 May 22. Review.

PMID:
23701732
11.

The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Aliment Pharmacol Ther. 2013 Feb;37(3):323-31. doi: 10.1111/apt.12169. Epub 2012 Nov 29.

12.

Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity.

Axon A, May FE, Gaughan LE, Williams FM, Blain PG, Wright MC.

Toxicology. 2012 Aug 16;298(1-3):40-51. doi: 10.1016/j.tox.2012.04.014. Epub 2012 May 3.

PMID:
22562034
13.

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ; European Helicobacter Study Group.

Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.

PMID:
22491499
14.

Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Am J Gastroenterol. 2012 Jun;107(6):912-21. doi: 10.1038/ajg.2012.69. Epub 2012 Apr 3.

PMID:
22472745
15.

Clinical outcome of acute upper gastrointestinal hemorrhage among patients admitted to a government hospital in Egypt.

Gado AS, Ebeid BA, Abdelmohsen AM, Axon AT.

Saudi J Gastroenterol. 2012 Jan-Feb;18(1):34-9. doi: 10.4103/1319-3767.91737.

16.

Prevalence of microscopic colitis in patients with chronic diarrhea in Egypt: a single-center study.

Gado AS, Ebeid BA, El Hindawi AA, Akl MM, Axon AT.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):383-6. doi: 10.4103/1319-3767.87178.

17.
18.

Review article: methods of measuring gastric acid secretion.

Ghosh T, Lewis DI, Axon AT, Everett SM.

Aliment Pharmacol Ther. 2011 Apr;33(7):768-81. doi: 10.1111/j.1365-2036.2010.04573.x. Epub 2011 Jan 24. Review.

19.

Epidemiology of Helicobacter pylori infection and public health implications.

Ford AC, Axon AT.

Helicobacter. 2010 Sep;15 Suppl 1:1-6. doi: 10.1111/j.1523-5378.2010.00779.x. Review.

PMID:
21054646
20.

A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).

Sonwalkar SA, Rotimi O, Scott N, Verghese E, Dixon M, Axon AT, Everett SM.

Histopathology. 2010 Jun;56(7):900-7. doi: 10.1111/j.1365-2559.2010.03571.x.

PMID:
20636793
21.

Sedation in digestive endoscopy: the Athens international position statements.

Cohen LB, Ladas SD, Vargo JJ, Paspatis GA, Bjorkman DJ, Van der Linden P, Axon AT, Axon AE, Bamias G, Despott E, Dinis-Ribeiro M, Fassoulaki A, Hofmann N, Karagiannis JA, Karamanolis D, Maurer W, O'Connor A, Paraskeva K, Schreiber F, Triantafyllou K, Viazis N, Vlachogiannakos J.

Aliment Pharmacol Ther. 2010 Aug;32(3):425-42. doi: 10.1111/j.1365-2036.2010.04352.x. Epub 2010 May 8.

22.

The PXR is a drug target for chronic inflammatory liver disease.

Wallace K, Cowie DE, Konstantinou DK, Hill SJ, Tjelle TE, Axon A, Koruth M, White SA, Carlsen H, Mann DA, Wright MC.

J Steroid Biochem Mol Biol. 2010 May 31;120(2-3):137-48. doi: 10.1016/j.jsbmb.2010.04.012. Epub 2010 Apr 21.

23.

The use of propofol by gastroenterologists: medico-legal issues.

Axon AE.

Digestion. 2010;82(2):110-2. doi: 10.1159/000285570. Epub 2010 Apr 21.

24.

Throat spray, sedation or anaesthetic?

Axon AT.

Digestion. 2010;82(2):77-9. doi: 10.1159/000285337. Epub 2010 Apr 21.

25.

Quality assurance and credentialing in endoscopy: the standard of care for the future?

Axon AT.

Endoscopy. 2009 Dec;41(12):1078-9. doi: 10.1055/s-0029-1215357. Epub 2009 Dec 4. No abstract available.

PMID:
19967623
26.

The Calcium Carbonate Breath Test, a noninvasive test of stimulated gastric acid secretion: preliminary communication.

Clough MR, Axon AT.

Eur J Gastroenterol Hepatol. 2009 Mar;21(3):266-72. doi: 10.1097/MEG.0b013e328321837e.

PMID:
19279471
27.

The pathogenesis of colorectal cancer. Foreword.

Axon AT.

Gastrointest Endosc. 2008 Oct;68(4 Suppl):S2. doi: 10.1016/j.gie.2008.09.004. No abstract available.

PMID:
18805237
28.

Is diagnostic and therapeutic endoscopy currently appropriate?: suggestions for improvement.

Axon A.

Best Pract Res Clin Gastroenterol. 2008;22(5):959-70. doi: 10.1016/j.bpg.2008.07.003. Review.

PMID:
18790441
29.

Educational training workshop in Helicobacter pyloriBologna.

Axon A, Tytgat G.

Gut. 1998 Jul;43(Suppl 1):S1. No abstract available.

30.

A screen-and-treat policy for Helicobacter pylori in Western Europe is affordable and would be effective.

Axon A.

Helicobacter. 2008 Aug;13(4):231-3. doi: 10.1111/j.1523-5378.2008.00619.x. No abstract available.

PMID:
18665929
31.

Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Aliment Pharmacol Ther. 2008 Oct 15;28(8):1013-20. doi: 10.1111/j.1365-2036.2008.03813.x. Epub 2008 Jul 24.

32.

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Am J Gastroenterol. 2008 May;103(5):1229-39; quiz 1240. doi: 10.1111/j.1572-0241.2007.01740.x. Epub 2008 Mar 26.

PMID:
18371141
33.
34.

A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: inhibition of NF-kappaB?

Axon A, Cowie DE, Mann DA, Wright MC.

Toxicology. 2008 Apr 3;246(1):40-4. doi: 10.1016/j.tox.2007.12.008. Epub 2007 Dec 23. Review.

PMID:
18194834
35.

Ethical and legal implications in seeking and providing a second medical opinion.

Axon A, Hassan M, Niv Y, Beglinger C, Rokkas T.

Dig Dis. 2008;26(1):11-7. Epub 2007 Dec 14.

PMID:
18097139
36.

How to influence health providers.

Axon A.

Helicobacter. 2007 Nov;12 Suppl 2:80-4. Review.

PMID:
17991182
37.

Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.

Ford AC, Forman D, Nathan J, Crocombe WD, Axon AT, Moayyedi P.

Aliment Pharmacol Ther. 2007 Nov 1;26(9):1267-75.

38.

Mycophenolate mofetil therapy for refractory inflammatory bowel disease.

Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ.

Inflamm Bowel Dis. 2007 Dec;13(12):1488-92.

PMID:
17924566
39.

Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study.

Ford AC, Forman D, Bailey AG, Goodman KJ, Axon AT, Moayyedi P.

Int J Epidemiol. 2007 Dec;36(6):1327-33. Epub 2007 Sep 28.

PMID:
17905807
40.

Low-grade dysplasia in Barrett's esophagus has a high risk of progression.

Lim CH, Treanor D, Dixon MF, Axon AT.

Endoscopy. 2007 Jul;39(7):581-7.

PMID:
17611911
41.

Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006.

Ladas SD, Novis B, Triantafyllou K, Schoefl R, Rokkas T, Stanciu C, Isaacs P, Willich SN, Ronn O, Dremel H, Livadas G, Egan BJ, Boyacioglu S, Selimovic A, Pulanic R, Karagiannis JA, Van Vooren JP, Kouroumalis E, O'Morain C, Nowak A, Deviere J, Malfertheiner P, Axon A.

Endoscopy. 2007 Jun;39(6):556-65. No abstract available.

42.

Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study.

Ford AC, Forman D, Bailey AG, Cook MB, Axon AT, Moayyedi P.

Am J Gastroenterol. 2007 May;102(5):957-65. Epub 2007 Feb 21.

PMID:
17313501
43.

Symptoms and diagnosis of gastric cancer at early curable stage.

Axon A.

Best Pract Res Clin Gastroenterol. 2006;20(4):697-708. Review.

PMID:
16997154
44.

Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Gut. 2007 Mar;56(3):321-7. Epub 2006 Aug 14.

45.
46.

Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients.

Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, Tompkins D, Axon A.

Gut. 2006 Nov;55(11):1545-52. Epub 2006 Apr 7.

47.

A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Gastroenterology. 2005 Dec;129(6):1910-7.

PMID:
16344059
48.

Helicobacter pylori: what do we still need to know?

Axon A.

J Clin Gastroenterol. 2006 Jan;40(1):15-9. Review.

PMID:
16340627
49.

Association between Helicobacter pylori infection and adult height.

Moayyedi P, Forman D, Duffett S, Mason S, Brown J, Crocombe W, Feltbower R, Axon A; Leeds HELP Study Group.

Eur J Epidemiol. 2005;20(5):455-65.

PMID:
16080594
50.

Review article: gastro-oesophageal reflux disease--the extent of the problem.

Moayyedi P, Axon AT.

Aliment Pharmacol Ther. 2005 Aug;22 Suppl 1:11-9. Review.

Supplemental Content

Support Center